GOSSAMER BIO, INC. Mentioned by Other
Announcements and disclosures made by other companies that explicitly identify this company. Each entry names the announcing company, publication date and relationship described. Includes supply, licensing, customer, property and other business relationships when disclosed. Company filings are labelled separately from newsroom announcements. Announced agreements do not prove a payment was made; absent amounts remain missing. All retained historical announcements remain available.
| Announced | Announcing company | Publication type | Relationship | What they announced | Disclosed amount | Term | Document |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | | $6.326B | 25.62 |
|---|